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Abstract Links between environmental chemicals and hu-
man health have emerged, but the effects on sleep health were
less studied. Therefore, the aim of the present study was to
investigate the relationships of different sets of environmental
chemicals and common sleep troubles in a national and
population-based setting. Data were retrieved from the
United States National Health and Nutrition Examination
Surveys, 2005–2006 including demographics, serum mea-
surements, lifestyle factors, self-reported sleep troubles, and
urinary environmental chemical concentrations. Statistical
analyses including descriptive statistics, t-test, chi-square test,
and survey-weighted logistic regression models were per-
formed. Of all 5563 Americans aged 18–85, 2331 (42.0%)
had wake-up at night, 2914 (52.5%) felt unrested during the
day, 740 (13.4%) had leg jerks while sleeping, and 1059
(19.1%) had leg cramps for 2+ times a month. Higher levels
of urinary arsenic, phthalates, and polyfluoroalkyl compounds
were associated with wake-up at night. Higher levels of uri-
nary 4-tert-octylphenol and polyfluoroalkyl compounds were
associated with being unrested during the day. Higher levels
of urinary arsenic, polyaromatic hydrocarbons, and
polyfluoroalkyl compounds were associated with leg jerks
while sleeping. Higher levels of urinary pesticides, heavy
metals, phthalates, and polyaromatic hydrocarbons were asso-
ciated with leg cramps while sleeping. However, there were
no significant associations with other environmental
chemicals such as parabens, bisphenol A, benzophenone-3,
triclosan, perchlorate, nitrate, or thiocyanate. Eliminating ar-
senic, heavy metals, phthalate, pesticides, polyaromatic hy-
drocarbons, and polyfluoroalkyl compounds to improve sleep
health might be considered while understanding the biological
pathway with a longitudinal or experimental approach in fu-
ture research would be suggested.
Keywords Sleep . Arsenic . Pesticide . Heavymetal .
Phthalate . Phenol . Polyfluoroalkyl . Hydrocarbon .
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Introduction
Evidence before this study
Links between environmental chemicals and human health in
the American adults including hypertension, cardiovascular
disease, food allergy, oral health, emotional support, and cog-
nitive function have emerged (Shiue 2015a, b, c, d, 2014a, b,
2013a, b, c), but the effects on sleep health, such as time to fall
asleep as one of the indicators, were relatively less studied.
Epidemiological studies have shown that the prevalence of
sleep disturbances lies between 20 and 30% and increases
with age, particularly in female (Zeitlhofer et al. 2000).
Among the American adults, in studying risk contributors
for sleep health it was observed that vitamin D level, a hor-
mone that interacts with intranuclear receptors to effect tran-
scriptional changes in many cell types including those in gut,
bone, breast, prostate, brain, skeletal muscle, and the immune
system (McCarty et al. 2014), could also play an important
role in time to fall asleep at bedtime (Shiue 2013d).
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Study aim
However, it is unclear whether environmental chemicals in ad-
dition to sun radiation could influence sleep patterns as well.
Following this context, therefore, the aim of the present study
was to investigate the relationships of different sets of environ-
mental chemicals and some common sleep troubles in a nation-
al and population-based setting using an independent dataset.
Methods
Study sample
As described online (more details via http://www.cdc.
gov/nchs/nhanes.htm), the United States National Health and
Nutrition Examination Surveys (NHANES) has been a nation-
al, population-based, multi-year, cross-sectional study since
the 1980s. Study samples are representative of the civilian,
non-institutionalized US population. Information on demo-
graphics, serum measurements, lifestyle factors, sleep pattern
(Question: How does it usually take to fall asleep at bedtime?
More details via http://wwwn.cdc.gov/Nchs/Nhanes/2005-
2006/SLQ_D.htm) and urinary environmental chemical
concentrations was obtained by household interview. In the
current analysis, the 2005–2006 cohort as the most recent
study cohort with all the required information mentioned
above was selected for statistical analysis (more details via
http://wwwn.cdc.gov/nchs/nhanes/search/nhanes05_06.
aspx). Informed consents were obtained from participating
subjects by the NHANES researchers.
Biomonitoring
Urines were only collected in a representative subsample with-
in 10 days of the household interview, being one third of the
whole study cohort (more details via http://www.cdc.
gov/nchs/data/nhanes/nhanes_05_06/lab_d.pdf), to measure
environmental chemical concentrations in urine among
people aged 6 and above (more details via http://www.cdc.
gov/nchs/data/nhanes/nhanes_03_04/environmentalhealth_03.
pdf). Urine specimens were processed, stored under
appropriate frozen (−20 °C) conditions, and shipped to the
Division of Environmental Health Laboratory Sciences,
National Center for Environmental Health, Centers for
Disease Control and Prevention for analysis.
The inductively coupled plasma-mass spectrometry (ICP-
MS) method (Mulligan et al. 1990) was used to measure the
following 12 elements in urine: beryllium (Be), cobalt (Co),
molybdenum (Mo), cadmium (Cd), antimony (Sb), cesium
(Cs), tungsten (W), tin (Sn), strontium (Sr), manganese (Mn)
thallium (TI), lead (Pb), and uranium (U). Urine samples are
diluted 1 + 9 with 2% (v/v), double-distilled, concentrated
nitric acid containing both iridium (Ir) and rhodium (Rh) for
multi-internal standardization (more details via http://wwwn.
cdc.gov/Nchs/Nhanes/2005-2006/UHM_D.htm). The test
principle utilized high-performance liquid chromatography-
electrospray ionization-tandem mass spectrometry (HPLC-
ESI-MS/MS) for the quantitative detection in urine of the fol-
lowing phthalate metabolites: monomethyl phthalate (MMP),
monoethyl phthalate (MEP), monobutyl phthalate (MBP),
monoisobutyl phthalate (MIBP), mono(3-carboxypropyl)
phthalate (MCPP), mono(2-ethylhexyl) phthalate (MEHP),
monobenzyl phthalate (MBzP), monoisononyl phthalate
(MNP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP),
mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP),
mono(2-ethyl-5-carboxypentyl) phthalate (MECPP),
monocarboxyoctyl phthalate (MCOP), monocarboxynonyl
phthalate (MCNP), and cyclohexane-1,2-dicarboxylic acid-
mono(hydroxy-isononyl) ester (MHNCH). Urine samples are
processed using enzymatic deconjugation of the
glucuronidated metabolites followed by on-line solid phase
extraction (SPE) coupled with reversed phase HPLC-ESI-
MS/MS. Assay precision is improved by incorporating isoto-
pically labeled internal standards of the phthalate metabolites
and MHNCH (more details via http:/ /wwwn.cdc.
gov/Nchs/Nhanes/2005-2006/PHTHTE_D.htm).
Total and specific urine arsenic concentrations were deter-
mined by using inductively coupled-plasma dynamic reaction
cell-mass spectrometry (ICP-DRC-MS) (more details via
http://wwwn.cdc.gov/Nchs/Nhanes/2005-2006/UAS_D.htm)
Urine is analyzed because urinary excretion is the major
pathway for eliminating arsenic from the mammalian body.
The method used on-line SPE coupled to HPLC and tandem
mass spectrometry (HPL/CMS/MS). A sensitive method, SPE
coupled on-line to HPLC and tandem mass spectrometry
(MS/MS), was used for measuring bisphenol A (BPA), 4-tert-
octylphenol (tOP), benzophenone-3 (BP-3), one chlorophenols
triclosan, four parabens, and pesticides (more details via
http://wwwn.cdc.gov/Nchs/Nhanes/2005-2006/EPH_D.htm
and http://wwwn.cdc.gov/Nchs/Nhanes/2005-2006/PP_D.
htm). A quantitative procedure was used for the measurement
of nitrate, perchlorate, and thiocyanate in human urine using
ion chromatography coupled with electrospray tandem mass
spectrometry. Chromatographic separation is achieved using
an IonPac AS16 column with sodium hydroxide as the
eluant. The eluant from the column is ionized using an
electrospray interface to generate and transmit negative ions
into the mass spectrometer (more details via http://wwwn.cdc.
gov/Nchs/Nhanes/2005-2006/PTH_D.htm).
To detect and measure metabolites of polyaromatic hydro-
c a r b o n s (mo r e d e t a i l s v i a h t t p : / / wwwn . c d c .
gov/Nchs/Nhanes/2005-2006/PAH_D.htm), the procedure
involved enzymatic hydrolysis of glucuronidated/sulfated
OH-polyaromatic hydrocarbons metabolites in urine, extrac-
tion, derivatization, and analysis using isotope dilution
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capillary gas chromatography tandem mass spectrometry
(GC-MS/MS). Ion transitions specific to each analyte and
carbon-13 labeled internal standards are monitored, and the
abundances of each ion are measured. Moreover, solid phase
ex t rac t ion coup led to h igh-pe r fo rmance l iqu id
chromatography-turbo ion spray ionization-tandem mass
spectrometry (online SPE-HPLC-TIS-MS/MS) was used for
the quantitative detection of perfluorooctane sulfonamide
(PFOSA), 2-(N-methyl-perfluorooctane sulfonamido) acetic
acid (Me-PFOSA-AcOH), 2-(N-ethyl-perfluorooctane
su l f on am ido ) a c e t i c a c i d (E t - PFOSA-AcOH) ,
perfluorobutane sulfonate (PFBuS), perfluorohexane sulfo-
nate (PFHxS), perfluorooctane sulfonate (PFOS),
perfluoroheptanoate (PFHpA), perfluorooctanoate (PFOA),
perfluorononanoate (PFNA), perfluorodecanoate (PFDeA),
perfluoroundecanoate (PFUA), and perfluorododecanoate
( PFDoA) (mo r e d e t a i l s v i a h t t p : / /wwwn . cd c .
gov/Nchs/Nhanes/2005-2006/PFC_D.htm).
Statistical analysis
Americans aged 18–85 with all the required study vari-
ables were included in the current statistical analysis.
Urinary environmental chemical concentrations were all
log transformed because they were highly skewed to one
side. Associations of urinary environmental chemical con-
centrations (x variables) and the five common sleep trou-
bles in the past month (y variables; more details via
http://wwwn.cdc.gov/Nchs/Nhanes/2005-2006/SLQ_D.
htm) were examined by using survey-weighted logistic
regression models, with P < 0.05 considered statistically
significant. Covariates including urinary creatinine, age,
sex, ratio of family income to poverty (proxy of socioeco-
nomic status), body mass index, serum cotinine (biomark-
er of smoking status), vitamin D levels (more details via
http://wwwn.cdc.gov/Nchs/Nhanes/2005-2006/VID_D.
htm), and physical activity level were adjusted. Statistical
software STATA version 13.0 (STATA, College Station,
Texas, USA; more details via http://www.stata.com/) was
used to conduct all the analyses.
Table 1 Characteristics of the study participants aged 18–85
(N = 5563)
N (%) or mean ± SD
Age 45.2 ± 20.3
18–39 2507 (45.1)
40–59 1486 (26.7)
60–85 1570 (28.2)
Sex
Male 2675 (48.1)
Female 2888 (51.9)
Body mass index 28.5 ± 6.8
<18.5 101 (1.9)
18.5–24.9 1620 (30.9)
25–29.9 1734 (33.1)
30+ 1782 (34.0)
Ratio of family income to poverty
0–4.9 4318 (82.0%)
5+ 951 (18.1%)
Serum cotinine (ng/mL) 55.8 ± 121.3
Serum vitamin D (ng/mL) 21.3 ± 9.4
Alcohol status
≥12 drinks 2994 (68.8%)
Less than 12 drinks 1355 (31.2%)
Physical activity level
Engaging moderately 3026 (54.4%)
Not moderately 2535 (45.6%)
Table 2 Characteristics
of sleep troubles in the
study participants aged
18–85 (N = 5563)
Number (%)
Wake-up at night
Never 2134 (38.4)
1 time a month 1091 (19.6)
2–4 times a month 1269 (22.8)
5–15 times a month 670 (12.0)
16–30 times a month 392 (7.1)
Unrested during the day
Never 1746 (31.4)
1 time a month 893 (16.1)
2–4 times a month 1546 (27.8)
5–15 times a month 848 (15.2)
16–30 times a month 520 (9.4)
Overly sleepy during the day
Never 1908 (34.3)
1 time a month 1180 (21.2)
2–4 times a month 1450 (26.1)
5–15 times a month 663 (11.9)
16–30 times a month 352 (6.3)
Leg jerks while sleeping
Never 4389 (78.9)
1 time a month 391 (7.0)
2–4 times a month 451 (8.1)
5–15 times a month 175 (3.2)
16–30 times a month 114 (2.1)
Leg cramps while sleeping
Never 3833 (68.9)
1 time a month 663 (11.9)
2–4 times a month 720 (12.9)
5–15 times a month 236 (4.2)
16–30 times a month 103 (1.9)
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Ethics concerns
Since there are only secondary data analyses employed with-
out any participant personal information identified by
extracting statistical data from the NHANES website in the
present study, no further ethics approval for conducting the
present study is required (more details via http://www.
ethicsguidebook.ac.uk/Secondary-analysis-106).
Results
Table 1 shows characteristics of the included study partici-
pants. Of all 5563 Americans aged 18–85, 2331 (42.0%)
had wake-up at night, 2914 (52.5%) felt unrested during the
day, 740 (13.4%) had leg jerks while sleeping, and 1059
(19.1%) had leg cramps while sleeping for 2+ times a month.
Table 2 lists the frequency of common sleep troubles in the
Table 3 Associations between urinary chemicals and wake-up at night in adults
No wake-up at night
(n = 3225, 58.1%)
Wake-up at night
(n = 2331, 42.0%)
OR (95% CI) P value
Arsenic (n = 1581, μg/L)
Total arsenic 23.5 ± 73.7 22.2 ± 51.9 1.08 (0.97–1.19) 0.136
Arsenous acid 0.9 ± 0.7 0.9 ± 0.3 0.79 (0.31–2.01) 0.607
Arsenic acid 0.7 ± 0.3 0.8 ± 0.5 1.86 (0.99–3.48) 0.053
Arsenobetaine 12.7 ± 59.2 12.4 ± 41.8 1.03 (0.94–1.14) 0.476
Arsenocholine 0.4 ± 0.3 0.5 ± 0.3 1.05 (0.68–1.62) 0.805
Dimethylarsonic acid 5.8 ± 9.6 5.7 ± 7.9 1.03 (0.87–1.22) 0.715
Monomethylarsonic acid 1.0 ± 1.1 1.0 ± 1.2 1.08 (0.74–1.56) 0.681
Trimethylarsine oxide 0.7 ± 0.2 0.7 ± 0.2 1.51 (1.29–1.76) <0.001
Phthalate (n = 1488, μg/mL)
Mono(carboxyoctyl) 16.4 ± 111.7 16.9 ± 73.2 1.00 (0.90–1.13) 0.936
Mono(carboxynonyl) 5.5 ± 16.2 6.7 ± 31.1 0.96 (0.83–1.10) 0.514
Mono-2-ethyl-5-carboxypentyl 112.0 ± 356.7 93.9 ± 235.2 0.90 (0.80–1.00) 0.048
Mono-n-butyl 48.4 ± 338.5 35.0 ± 45.3 0.97 (0.85–1.10) 0.625
Mono(3-carboxypropyl) 4.3 ± 15.7 4.1 ± 10.0 1.01 (0.91–1.13) 0.813
Monoethyl 433.8 ± 1084.7 508.1 ± 1253.9 1.04 (0.94–1.14) 0.432
Mono(2-ethyl-5-hydroxyhexyl) 84.7 ± 308.3 75.0 ± 211.9 0.91 (0.82–1.01) 0.086
Mono(2-ethyl)-hexyl 13.2 ± 71.9 10.0 ± 31.4 0.94 (0.83–1.07) 0.330
Monoisobutyl 26.2 ± 477.4 11.1 ± 19.9 0.96 (0.84–1.10) 0.541
Mono-n-methyl 3.5 ± 12.9 5.5 ± 37.7 1.05 (0.95–1.16) 0.290
Monoisononyl 2.0 ± 8.6 1.8 ± 5.5 1.15 (0.92–1.44) 0.193
Mono(2-ethyl-5-oxohexyl) 53.0 ± 199.4 45.7 ± 124.5 0.91 (0.81–1.02) 0.096
Monobenzyl 35.4 ± 542.2 17.6 ± 33.3 0.96 (0.85–1.09) 0.508
Monocyclohexyl 0.5 ± 0.5 0.5 ± 1.1 1.88 (1.02–3.46) 0.044
Polyfluoroalkyl compounds (n = 1591, μg/mL)
Perfluorooctanoic acid 4.5 ± 3.3 4.5 ± 3.7 0.95 (0.74–1.21) 0.649
Perfluorooctane sulfonic acid 21.0 ± 15.9 22.3 ± 20.9 0.99 (0.83–1.20) 0.947
Perfluorohexane sulfonic acid 2.6 ± 3.3 2.4 ± 2.6 0.99 (0.89–1.10) 0.864
2-(N-ethyl-PFOSA) acetate 0.2 ± 0.2 0.2 ± 0.1 1.50 (1.08–2.09) 0.020
2-(N-methyl-PFOSA) acetate 0.6 ± 0.8 0.6 ± 0.6 1.08 (0.96–1.22) 0.183
Perfluorodecanoic acid 0.5 ± 0.6 0.5 ± 0.9 0.98 (0.83–1.17) 0.838
Perfluorobutane sulfonic acid 0.1 ± 0.2 0.1 ± 0.1 0.98 (0.55–1.75) 0.936
Perfluoroheptanoic acid 0.4 ± 0.4 0.3 ± 0.4 0.99 (0.82–1.19) 0.887
Perfluorononanoic acid 1.3 ± 1.1 1.4 ± 1.4 1.03 (0.83–1.29) 0.747
Perfluorooctane sulfonamide 0.1 ± 0.2 0.1 ± 0.1 1.09 (0.88–1.36) 0.389
Perfluoroundecanoic acid 0.3 ± 0.5 0.3 ± 0.6 0.99 (0.82–1.19) 0.908
Perfluorododecanoic acid 0.1 ± 0.1 0.1 ± 0.1 1.72 (1.08–2.73) 0.026
Adjusted for age, sex, body mass index, ratio of family income to poverty, serum cotinine (smoking status), vitamin D level, physical activity level,
urinary creatinine and subsample weighting
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study participants. Tables 3, 4, 5, and 6 present the associa-
tions between urinary chemical concentrations and common
sleep troubles, except for feeling overly sleeping during the
day with no association found, accordingly. To be specific,
higher levels of urinary arsenic, phthalates, and
polyfluoroalkyl compounds were associated with wake-up at
night. Higher levels of urinary 4-tert-octylphenol and
polyfluoroalkyl compounds were associated with being
unrested during the day. Higher levels of urinary arsenic,
polyaromatic hydrocarbons, and polyfluoroalkyl compounds
were associated with leg jerks while sleeping. Higher levels of
urinary pesticides, heavy metals, phthalates, and polyaromatic
hydrocarbons were associated with leg cramps while sleeping.
There were no significant associations with other environmen-
tal chemicals such as parabens, bisphenol A, benzophenone-3,
triclosan, perchlorate, nitrate, or thiocyanate (data not shown).
Discussion
Arsenic and sleep
Low level of arsenic exposure was previously observed to be
associated with sleep disturbance in copper smelter workers
(n = 680; Lilis et al. 1985). Long-term poisoning was also
found to affect sleep disorder in children (Ishi and Tamaoka
2015). In the present study, higher levels of urinary arsenic
were found to be associated with wake-up at night and leg jerk
while sleeping. However, to date no experimental research
was available to confirm the biological mechanism yet.
Pesticides and sleep
Pesticide exposure, particularly 2,4,5-trichlorophenol, was re-
cently found to influence idiopathic REM sleep behavior dis-
order in older adults (n = 694; Postuma et al. 2012; Neuberger
et al. 1998). In the limited experimental research, exposure to
pesticides seemed to reduce sleep time in male mice (21–24 g;
Chaturvedi 1993). In the present study using national repre-
sentative human sample, 2,5-dichlorophenol and 2,4-dichlo-
rophenol showed borderline associations with leg cramps in
sleeping. This would need future longitudinal or experimental
research to confirm or refute the findings in order to rule out
the statistical significance by chance.
Heavy metals and sleep
Uranium might directly affect the brain. Previously, it was
observed that chronic uranium exposure (40 mg l(−1) in
drinking water, for 90 days) increased in rapid eye movement
sleep in rats (Lestaevel et al. 2005). In the present study, the
consistent finding was shown in higher levels of urinary ura-
nium and urinary antimony and leg cramps in sleeping.
Phthalates and sleep
The intravenous or intraperitoneal administration of bis(2-
ethylhexyl) phthalate could prolong hexobarbital sleep time
in mice and rats by enlarging the lipophilic pool (Swinyard
et al. 1976). In the present study, monocyclohexyl showed an
association with wake-up at night, and mono(carboxynonyl)
Table 4 Associations between urinary chemicals and unrested during the day in adults
No unrested
(n = 2639, 47.5%)
Unrested during the day
(n = 2914, 52.5%)
OR (95% CI) P value
Phenol (n = 1486, ng/mL)
4-Tert-octylphenol 0.2 ± 0.3 0.2 ± 0.1 1.93 (1.02–3.67) 0.044
Polyfluoroalkyl compounds (n = 1592, μg/mL)
Perfluorooctanoic acid 4.6 ± 3.3 4.5 ± 3.6 1.01 (0.84–1.22) 0.902
Perfluorooctane sulfonic acid 22.4 ± 19.5 20.7 ± 16.9 1.09 (0.93–1.28) 0.278
Perfluorohexane sulfonic acid 2.5 ± 2.9 2.5 ± 3.2 1.03 (0.94–1.14) 0.467
2-(N-ethyl-PFOSA) acetate 0.2 ± 0.1 0.2 ± 0.3 1.29 (0.82–2.00) 0.248
2-(N-methyl-PFOSA) acetate 0.6 ± 0.7 0.6 ± 0.7 1.24 (1.02–1.51) 0.035
Perfluorodecanoic acid 0.5 ± 0.9 0.5 ± 0.6 1.10 (0.92–1.30) 0.265
Perfluorobutane sulfonic acid 0.1 ± 0.1 0.1 ± 0.2 1.42 (1.02–1.98) 0.041
Perfluoroheptanoic acid 0.3 ± 0.3 0.4 ± 0.5 1.00 (0.77–1.31) 0.974
Perfluorononanoic acid 1.4 ± 1.3 1.4 ± 1.2 1.14 (0.95–1.38) 0.148
Perfluorooctane sulfonamide 0.1 ± 0.1 0.1 ± 0.2 1.15 (0.93–1.43) 0.176
Perfluoroundecanoic acid 0.3 ± 0.7 0.3 ± 0.4 1.08 (0.85–1.36) 0.502
Perfluorododecanoic acid 0.1 ± 0.04 0.2 ± 0.1 2.11 (0.79–5.62) 0.126
Adjusted for age, sex, body mass index, ratio of family income to poverty, serum cotinine (smoking status), vitamin D level, physical activity level,
urinary creatinine and sub-sample weighting
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and mono(3-carboxypropyl) showed associations with leg
cramps in sleeping. These would also need future longitudinal
or experimental research to confirm or refute the findings in
order to rule out the statistical significance by chance.
Polyaromatic hydrocarbons and sleep
There was no direct research evidence on the relationship of
polyaromatic hydrocarbons and sleep health. In the present
study, it is the first time to show that higher urinary polyaromatic
hydrocarbons, such as 2-hydroxyfluorene, 9-hydroxyfluorene,
2-hydroxyphenanthrene, and 1-hydroxypyrene, were
significantly associated with leg cramps in sleeping. Similarly,
urinary 2-hydroxyfluorene, 3-hydroxyfluorene, 1-
hydroxypyrene were significantly associated with leg jerks in
sleeping. Levels of other known urinary polyaromatic hydrocar-
bons were also higher in people with sleep disturbances, but the
statistical significance was not reached.
Polyfluoroalkyl compounds and sleep
There were no indications that there could be any associ-
ation between polyfluoroalkyl compounds and sleep
health in the past. Polyfluoroalkyl compounds in human
Table 5 Associations between urinary chemicals and leg jerks while sleeping in adults
No leg jerks
(n = 4780, 86.6%)
Leg jerks while sleeping
(n = 740, 13.4%)
OR (95% CI) P value
Arsenic (n = 1567, μg/L)
Total arsenic 22.1 ± 56.7 28.8 ± 106.5 1.03 (0.88–1.21) 0.714
Arsenous acid 0.9 ± 0.6 0.9 ± 0.2 0.89 (0.32–2.45) 0.802
Arsenic acid 0.8 ± 0.4 0.8 ± 0.6 0.73 (0.28–1.94) 0.508
Arsenobetaine 11.7 ± 43.4 18.5 ± 92.2 0.99 (0.87–1.13) 0.869
Arsenocholine 0.4 ± 0.3 0.5 ± 0.3 1.02 (0.60–1.70) 0.951
Dimethylarsonic acid 5.8 ± 9.5 5.2 ± 4.7 0.96 (0.80–1.14) 0.586
Monomethylarsonic acid 1.0 ± 1.2 0.9 ± 0.6 0.97 (0.60–1.58) 0.904
Trimethylarsine oxide 0.7 ± 0.2 0.7 ± 0.4 1.72 (1.09–2.72) 0.022
Polyaromatic hydrocarbons (n = 1412, ng/L)
2-Hydroxyfluorene 722.2 ± 1257.0 912.4 ± 1540.5 1.21 (1.02–1.43) 0.029
3-Hydroxyfluorene 353.8 ± 880.4 461.8 ± 784.5 1.19 (1.02–1.39) 0.029
9-Hydroxyfluorene 649.8 ± 1237.2 703.3 ± 1243.4 1.21 (0.96–1.53) 0.104
1-Hydroxyphenanthrene 265.6 ± 528.0 259.6 ± 305.9 1.23 (0.97–1.55) 0.081
2-Hydroxyphenanthrene 123.4 ± 279.5 127.3 ± 174.7 1.17 (0.91–1.51) 0.207
3-Hydroxyphenanthrene 199.0 ± 486.5 223.6 ± 370.5 1.22 (0.95–1.56) 0.114
1-Hydroxypyrene 214.0 ± 627.3 279.9 ± 790.4 1.22 (1.03–1.45) 0.025
1-Hydroxynapthalene (1-naphthol) 22,657.5 ± 177,331.5 175,350.4 ± 1,968,678.0 1.05 (0.91–1.21) 0.497
2-Hydroxynapthalene (2-naphthol) 9312.6 ± 25,015.5 10,078.5 ± 14,846.3 1.02 (0.80–1.30) 0.849
4-Hydroxyphenanthrene 54.9 ± 99.4 50.6 ± 52.5 1.06 (0.85–1.33) 0.575
Polyfluoroalkyl compounds (n = 1584, μg/mL)
Perfluorooctanoic acid 4.5 ± 3.3 4.7 ± 4.1 1.05 (0.89–1.24) 0.523
Perfluorooctane sulfonic acid 21.4 ± 18.0 22.2 ± 19.0 1.05 (0.90–1.24) 0.488
Perfluorohexane sulfonic acid 2.5 ± 3.0 2.8 ± 3.1 1.06 (0.87–1.31) 0.528
2-(N-ethyl-PFOSA) acetate 0.2 ± 0.2 0.2 ± 0.1 0.94 (0.47–1.91) 0.867
2-(N-methyl-PFOSA) acetate 0.6 ± 0.7 0.6 ± 0.5 1.27 (1.12–1.44) 0.001
Perfluorodecanoic acid 0.5 ± 0.7 0.6 ± 0.9 1.03 (0.84–1.27) 0.744
Perfluorobutane sulfonic acid 0.1 ± 0.2 0.1 ± 0.1 1.65 (1.03–2.66) 0.040
Perfluoroheptanoic acid 0.3 ± 0.4 0.4 ± 0.7 1.26 (1.02–1.56) 0.035
Perfluorononanoic acid 1.4 ± 1.3 1.3 ± 1.2 1.05 (0.82–1.33) 0.694
Perfluorooctane sulfonamide 0.1 ± 0.2 0.1 ± 0.1 0.89 (0.66–1.21) 0.448
Perfluoroundecanoic acid 0.3 ± 0.5 0.3 ± 0.6 0.97 (0.77–1.21) 0.746
Perfluorododecanoic acid 0.1 ± 0.1 0.1 ± 0.1 1.39 (0.55–3.52) 0.466
Adjusted for age, sex, body mass index, ratio of family income to poverty, serum cotinine (smoking status), vitamin D level, physical activity level,
urinary creatinine and sub-sample weighting
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health is an under-studied area, mostly with a focus on
fetal growth, neuro-behavioral problems in infants or
children, or cognitive function in older adults (Bach
et al. 2015; Donauer et al. 2015; Power et al. 2013;
Table 6 Associations between urinary chemicals and leg cramps while sleeping in adults
No leg cramps
(n = 4496, 80.9%)
Leg cramps while sleeping
(n = 1059, 19.1%)
OR (95% CI) P value
Pesticides (n = 1489, μg/L)
2,5-dichlorophenol 228.2 ± 1242.6 175.0 ± 772.2 1.12 (1.02–1.23) 0.018
O-phenyl phenol 0.2 ± 0.6 0.3 ± 2.2 0.98 (0.72–1.35) 0.904
2,4-Dichlorophenol 7.4 ± 45.9 5.5 ± 24.0 1.17 (1.03–1.32) 0.017
2,4,5-Trichlorophenol 0.1 ± 0.3 0.1 ± 0.1 1.08 (0.86–1.37) 0.466
2,4,6-Trichlorophenol 0.7 ± 2.7 0.7 ± 2.4 0.91 (0.67–1.23) 0.511
Heavy metals (n = 1576, μg/L)
Barium 2.3 ± 3.9 2.2 ± 3.2 0.93 (0.81–1.06) 0.257
Cadmium 0.4 ± 0.4 0.5 ± 0.5 1.05 (0.91–1.21) 0.463
Cobalt 0.5 ± 1.2 0.8 ± 2.3 1.07 (0.87–1.30) 0.506
Cesium 2.3 ± 3.9 2.2 ± 3.2 0.92 (0.78–1.08) 0.278
Molybdenum 5.7 ± 4.0 5.4 ± 4.5 0.98 (0.79–1.20) 0.813
Lead 61.1 ± 53.1 57.7 ± 51.1 1.02 (0.80–1.29) 0.895
Antimony 1.0 ± 2.3 0.9 ± 0.8 1.22 (1.05–1.43) 0.015
Thallium 0.2 ± 1.3 0.1 ± 0.2 0.87 (0.72–1.05) 0.136
Tungsten 0.2 ± 0.1 0.2 ± 0.1 1.07 (0.91–1.26) 0.392
Uranium 0.1 ± 0.3 0.2 ± 0.4 1.27 (1.06–1.51) 0.011
Polyaromatic hydrocarbons (n = 1425, ng/L)
2-Hydroxyfluorene 738.5 ± 1275.0 764.3 ± 1373.7 1.19 (1.00–1.43) 0.054
3-Hydroxyfluorene 371.7 ± 904.2 340.3 ± 676.4 1.14 (0.96–1.36) 0.121
9-Hydroxyfluorene 644.6 ± 1212.2 692.2 ± 1320.2 1.28 (1.12–1.45) 0.001
1-Hydroxyphenanthrene 259.3 ± 520.7 284.1 ± 419.3 1.21 (0.98–1.50) 0.074
2-Hydroxyphenanthrene 121.5 ± 281.9 131.4 ± 191.6 1.24 (1.00–1.53) 0.046
3-Hydroxyphenanthrene 203.7 ± 499.2 189.1 ± 322.1 1.18 (0.97–1.43) 0.086
1-Hydroxypyrene 215.3 ± 639.9 245.8 ± 676.3 1.28 (1.10–1.50) 0.004
1-Hydroxynapthalene (1-naphthol) 23,290.6 ± 182,622.3 124,604.9 ± 1,616,734.0 1.05 (0.94–1.16) 0.368
2-Hydroxynapthalene (2-naphthol) 8859.9 ± 20,058.9 11,969.1 ± 36,521.9 1.14 (0.97–1.33) 0.104
4-Hydroxyphenanthrene 53.8 ± 97.5 55.6 ± 80.6 1.15 (0.92–1.43) 0.214
Phthalate (n = 1488, μg/mL)
Mono(carboxyoctyl) 17.8 ± 106.8 11.5 ± 20.3 1.10 (0.95–1.28) 0.174
Mono(carboxynonyl) 6.2 ± 25.8 5.3 ± 12.5 1.15 (1.02–1.31) 0.025
Mono-2-ethyl-5-carboxypentyl 103.8 ± 313.6 105.2 ± 291.9 1.06 (0.90–1.24) 0.489
Mono-n-butyl 41.7 ± 272.7 46.1 ± 162.8 1.13 (0.97–1.31) 0.100
Mono(3-carboxypropyl) 4.3 ± 14.7 3.9 ± 6.0 1.20 (1.02–1.42) 0.032
Monoethyl 480.7 ± 1212.1 404.0 ± 912.0 1.06 (0.98–1.14) 0.141
Mono(2-ethyl-5-hydroxyhexyl) 81.6 ± 280.8 75.6 ± 219.3 1.06 (0.92–1.21) 0.412
Mono(2-ethyl)-hexyl 12.4 ± 62.8 9.2 ± 26.6 1.06 (0.93–1.21) 0.360
Monoisobutyl 21.4 ± 397.3 11.7 ± 23.5 1.12 (1.00–1.26) 0.057
Mono-n-methyl 4.3 ± 27.5 4.9 ± 23.5 1.03 (0.87–1.21) 0.735
Monoisononyl 2.1 ± 8.2 1.2 ± 1.3 1.07 (0.81–1.43) 0.605
Mono(2-ethyl-5-oxohexyl) 50.5 ± 177.8 46.9 ± 136.1 1.04 (0.90–1.19) 0.587
Monobenzyl 29.3 ± 451.3 20.3 ± 45.1 1.06 (0.93–1.19) 0.357
Monocyclohexyl 0.5 ± 0.5 0.5 ± 1.7 1.38 (0.67–2.85) 0.353
Adjusted for age, sex, body mass index, ratio of family income to poverty, serum cotinine (smoking status), vitamin D level, physical activity level,
urinary creatinine and subsample weighting
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Maisonet et al. 2012; Hoffman et al. 2010). In the present
study using national representative human sample, the
new observations have consistently shown higher levels
o f u r i n a r y 2 - (N - e t h y l - P FOSA ) a c e t a t e a n d
perfluorododecanoic acid in people with wake-up at night,
higher levels of urinary 2-(N-methyl-PFOSA) acetate,
perfluorobutane sulfonic acid in people feeling unrested
during the day, and higher levels of 2-(N-methyl-
PFOSA) acetate, perfluorobutane sulfonic acid and
perfluoroheptanoic acid in people with leg jerks in
sleeping. However, to date there has been no experimental
research to confirm yet.
Strengths and limitations
The present study has a few strengths. Firstly, this study
was conducted in a large and nationally representative
human sample with mixed ethnicities and socioeconomic
status. Secondly, this was the first time to examine the
risk associations between different sets of environmental
chemical concentrations and common sleep troubles.
However, there are still some limitations that cannot be
ignored. First, there could be still other emerging
chemicals from the living environments that we might
not yet know and would need future research to further
identify and examine. Second, objective measurements on
sleep patterns were not available. Third, the causality can-
not be established in the present study due to the cross-
sectional study design in nature. Therefore, future studies
with longitudinal or experimental study designs to con-
firm or refute the current findings and, if at all, to under-
stand the persisting risk effects along the life course from
those mentioned above environmental chemicals would be
warranted.
Directions for future research, practice, and policy
Urinary arsenic, pesticides, heavy metals, phthalates,
polyaromatic hydrocarbons and polyfluoroalkyl compounds
were associated with common sleep troubles in adults For
future research, studies understanding the biological mecha-
nism and monitoring the risk effects along the life course with
a longitudinal or experimental approach would be needed. For
practice and policy, elimination of these environmental
chemicals in order to improve sleep health might be
considered.
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